<?xml version="1.0" encoding="UTF-8"?>
<p>
 <xref ref-type="fig" rid="f3">
  <bold>Figure 3</bold>
 </xref> shows the difference in median OS between patients with or without HAI by subgroup analysis. HAI was associated with a better OS in all subgroups including patients with extrahepatic metastasis (
 <xref ref-type="fig" rid="f4">
  <bold>Figure 4</bold>
 </xref>). Notedly, the difference was greater in subgroups without EHM, with higher tumor burden in the liver with synchronous liver metastasis. In these subgroups, HAI led to an increase of median OS more than 4 months.
</p>
